Compounds > dactinomycin

dactinomycin and xr5944

dactinomycin has been researched along with xr5944 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, J; Byers, SA; Price, DH; Sappal, DS; Schafer, B1
De Alba, A; Punchihewa, C; Sidell, N; Yang, D1

Other Studies

2 other study(ies) available for dactinomycin and xr5944

ArticleYear
The antiproliferative agent MLN944 preferentially inhibits transcription.
    Molecular cancer therapeutics, 2005, Volume: 4, Issue:8

    Topics: Antineoplastic Agents; Cell Proliferation; Dactinomycin; Growth Inhibitors; Humans; Nucleic Acid Synthesis Inhibitors; Phenazines; RNA Polymerase II; Transcription, Genetic; Tumor Cells, Cultured

2005
XR5944: A potent inhibitor of estrogen receptors.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:1

    Topics: Antineoplastic Agents; Dactinomycin; DNA, Neoplasm; Electrophoretic Mobility Shift Assay; Estrogens; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Luciferases; Phenazines; Receptors, Estrogen; Response Elements; Sp1 Transcription Factor; Substrate Specificity; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured

2007